Description
A selective inhibitor of PKC-induced NF-κB pathway activation (IC50 = 0.07 μM); inhibits IL-8 production in HEK293 cells (IC50 ≤ 0.1 μM), attenuates production of IL-2 by Jurkat T cells (IC50 ≤ 5 μM), and prevents proliferation of mouse B-lymphocytes (IC50 = ∼2 μM)
Formal name: 1-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-[2-[(3-hydroxypropyl)amino]-5,6-dimethyl-1H-benzimidazol-1-yl]-ethanone
Synonyms: ML-029
Molecular weight: 465.6
CAS: 758679-97-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|TNF-α/NF-κB Signaling||Research Area|Cell Biology|Cell Signaling|NF-κB Signaling||Research Area|Epigenetics, Transcription, & Translation|Transcription Factors||Research Area|Immunology & Inflammation|Adaptive Immunity||Research Area|Immunology & Inflammation|Autoimmunity||Research Area|Immunology & Inflammation|Innate Immunity|Pattern Recognition||Research Area|Immunology & Inflammation|Innate Immunity|STING||Research Area|Infectious Disease